| pubmed-article:3255797 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C0042789 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C0007776 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C0022655 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C0001613 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C1428114 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C1979874 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C1517378 | lld:lifeskim |
| pubmed-article:3255797 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:3255797 | pubmed:dateCreated | 1989-9-27 | lld:pubmed |
| pubmed-article:3255797 | pubmed:abstractText | 1. We evaluated human visual cortical contrast gain using visual evoked potential (VEP) measurements. The steady-state VEP was elicited by 7.5 Hz contrast modulation of a 6 cycles/deg sinusoidal grating. The stimulus may be regarded as the sum of a steady grating (C) and a counterphase grating of the same spatial frequency (delta C). The counterphase grating is modulated sinusoidally in time. 2. The VEP was measured to combinations of different modulation contrasts (delta C) and different mean levels of grating contrast (C) which produced stimuli with contrast modulation depths (delta C/C) ranging from 0.0625 to 1.0 ('on-off'). 3. The VEP signals were Fourier analysed and the amplitude and phase of the first (7.5 Hz) and second (15 Hz) harmonic frequency components were examined. The monocular VEP to a contrast-modulated grating contains significant first and second harmonic frequency components. 4. The amplitude and phase of the monocular VEP was plotted as a function of delta C for each mean level of contrast explored. The amplitudes of both the first and second harmonic frequency components grow with increasing delta C. However, the slope of each function depends on the mean contrast (C): with higher levels of C, the slope of the function is more shallow. Furthermore, at each level of C the amplitude of the first harmonic frequency saturates at a lower delta C than does the second harmonic frequency component. VEP amplitude is therefore not determined by the absolute contrast change (delta C) alone. The VEP phase of the first harmonic frequency shows less dependence on either modulation or on mean contrast; the phase of the second harmonic frequency component is strongly dependent on mean contrast (C) but not on delta C. 5. When the second harmonic amplitude component of the VEP response (R) is expressed as Ractual/Rmax, where Rmax is the response to C = delta C (i.e. 'on-off'), all second harmonic VEP functions can be well fitted with a power function. This is not the case for the function of the first harmonic amplitude data. 6. A dichoptic VEP was obtained by presenting the steady and counterphase gratings to opposite eyes. The dichoptic VEP, in distinction to the monocular VEP, contains only a second harmonic frequency component. The amplitude of the second harmonic frequency component grows with increasing delta C, similar to the function seen for the monocular VEP.(ABSTRACT TRUNCATED AT 400 WORDS) | lld:pubmed |
| pubmed-article:3255797 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3255797 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3255797 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3255797 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3255797 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:3255797 | pubmed:issn | 0022-3751 | lld:pubmed |
| pubmed-article:3255797 | pubmed:author | pubmed-author:Bodis-Wollner... | lld:pubmed |
| pubmed-article:3255797 | pubmed:author | pubmed-author:MarxM SMS | lld:pubmed |
| pubmed-article:3255797 | pubmed:author | pubmed-author:BobakPP | lld:pubmed |
| pubmed-article:3255797 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3255797 | pubmed:volume | 405 | lld:pubmed |
| pubmed-article:3255797 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3255797 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3255797 | pubmed:pagination | 421-37 | lld:pubmed |
| pubmed-article:3255797 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:meshHeading | pubmed-meshheading:3255797-... | lld:pubmed |
| pubmed-article:3255797 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3255797 | pubmed:articleTitle | Cortical contrast gain control in human spatial vision. | lld:pubmed |
| pubmed-article:3255797 | pubmed:affiliation | Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029. | lld:pubmed |
| pubmed-article:3255797 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3255797 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
